The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Abstract
Many tumour cells have elevated rates of glucose uptake but reduced rates of oxidative phosphorylation. This persistence of high lactate production by tumours in the presence of oxygen, known as aerobic glycolysis, was first noted by Otto Warburg more than 75 yr ago. How tumour cells establish this altered metabolic phenotype and whether it is essential for tumorigenesis is as yet unknown. Here we show that a single switch in a splice isoform of the glycolytic enzyme pyruvate kinase is necessary for the shift in cellular metabolism to aerobic glycolysis and that this promotes tumorigenesis. Tumour cells have been shown to express exclusively the embryonic M2 isoform of pyruvate kinase. Here we use short hairpin RNA to knockdown pyruvate kinase M2 expression in human cancer cell lines and replace it with pyruvate kinase M1. Switching pyruvate kinase expression to the M1 (adult) isoform leads to reversal of the Warburg effect, as judged by reduced lactate production and increased oxygen consumption, and this correlates with a reduced ability to form tumours in nude mouse xenografts. These results demonstrate that M2 expression is necessary for aerobic glycolysis and that this metabolic phenotype provides a selective growth advantage for tumour cells in vivo.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Paradoxically, decreased pyruvate kinase activity is associated with increased aerobic glycolysis, suggesting the activation of pyruvate kinase activity might be a way to target cancer (Christofk et al., 2008).”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Christofk et al., 2008
In the citing paper
“Tumor cells engineered to exclusively express the M2 isoform display increased lactate production characteristic of the Warburg effect and gain a growth advantage in vivo over M1-expressing tumors (57).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [57]
In the citing paper
“PKM2 promotes the Warburg effect and tumorigenesis (Christofk et al., 2008; Hitosugi et al., 2009).”
From Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1 (2011) · cites this paper as Christofk et al., 2008
In the citing paper
“Current data indicates that PKM2, when highly expressed, exists in an equilibrium of enzymatically inactive pyruvate kinase dimers (or monomers) which can translocate into the nucleus(Christofk et al., 2008; Hitosugi et al., 2009), and enzymatically active tetramers which are retained in the cytosol(Mazurek et al., 2005).”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Christofk et al., 2008
Citations
Cites
Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
DeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635
Muller, W., Sinn, E., Pattengale, P., Wallace, R., & Leder, P. (1988) · Cell · doi:10.1016/0092-8674(88)90184-5 · Cited by 1,246
Pyruvate kinase M2 is a phosphotyrosine-binding protein
Christofk, H. R., Vander Heiden, M. G., Wu, N., Asara, J. M., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06667 · Cited by 995
Self-citationMajumder, P. K., Febbo, P. G., Bikoff, R., Berger, R., Xue, Q., McMahon, L. M., Manola, J., Brugarolas, J., McDonnell, T. J., Golub, T. R., et al. (2004) · Nature Medicine · doi:10.1038/nm1052 · Cited by 964
Pyruvate kinase type M2 and its role in tumor growth and spreading
Mazurek, S., Boschek, C. B., Hugo, F., & Eigenbrodt, E. (2005) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2005.04.009 · Cited by 812
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 662
Growth factors can influence cell growth and survival through effects on glucose metabolism
Vander Heiden, M. G., Plas, D. R., Rathmell, J. C., Fox, C. J., Harris, M. H., & Thompson, C. B. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.17.5899-5912.2001 · Cited by 536
Self-citation
Cited by
Sorted by citations
Items 701–800 of 1,008
Yu, Z., Zhao, X., Huang, L., Zhang, T., Yang, F., Xie, L., Song, S., Miao, P., Zhao, L., Sun, X., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.508226 · Cited by 92
Redox-Based Escape Mechanism from Death: The Cancer Lesson
Pani, G., Giannoni, E., Galeotti, T., & Chiarugi, P. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2739 · Cited by 92
An integrative analysis of colon cancer identifies an essential function for PRPF6 in tumor growthPreprint
Adler, A. S., McCleland, M. L., Yee, S. F., Yaylaoglu, M., Hussain, S., Cosino, E., Quiñones, G., Modrusan, Z. D., Seshagiri, S., Torres, E., et al. (2014) · Genes & Development · doi:10.1101/gad.237206.113 · Cited by 92
Lim, J. Y. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i30.4037 · Cited by 91
Endothelial pyruvate kinase M2 maintains vascular integrity
Kim, B., Jang, C., Dharaneeswaran, H., Li, J., Bhide, M., Yang, S. H., Li, K., & Arany, Z. P. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120912 · Cited by 91
Li, L., Xiong, W., Lin, F., Hou, J., Chen, G., Peng, T., He, Y., Wang, R., Xu, Q., & Huang, Y. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02688-z · Cited by 91
Reshaping of Human Macrophage Polarization through Modulation of Glucose Catabolic Pathways
Izquierdo, E., Cuevas, V. D., Fernández‐Arroyo, S., Riera-Borrull, M., Orta‐Zavalza, E., Joven, J., Rial, E., Corbí, A. L., & Escribese, M. M. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1403045 · Cited by 91
Chen, Z., Wang, Z., Guo, W., Zhang, Z., Zhao, F., Zhao, Y., Jia, D., Ding, J., Wang, H., Yao, M., et al. (2014) · Oncogene · doi:10.1038/onc.2014.325 · Cited by 91
Yang, P., Li, Z., Li, H., Lu, Y., Wu, H., & Li, Z. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.02.032 · Cited by 91
A PKM2 signature in the failing heart
Rees, M. L., Subramaniam, J., Li, Y., Hamilton, D. J., Frazier, O. H., & Taegtmeyer, H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.122 · Cited by 91
Control of glioma cell death and differentiation by PKM2–Oct4 interaction
Morfouace, M., Lalier-Bretaudeau, L., Oliver, L., Cheray, M., Pecqueur, C., Cartron, P., & Vallette, F. M. (2014) · Cell Death and Disease · doi:10.1038/cddis.2013.561 · Cited by 91
Chaudhri, V. K., Salzler, G. G., Dick, S. A., Buckman, M. S., Sordella, R., Karoly, E. D., Mohney, R. P., Stiles, B. M., Elemento, O., Altorki, N. K., et al. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0437-t · Cited by 91
Loss of pyruvate kinase M2 limits growth and triggers innate immune signaling in endothelial cells
Stone, O. A., El-Brolosy, M. A., Wilhelm, K., Liu, X., Romão, A. M., Grillo, E., Lai, J. K. H., Günther, S., Jeratsch, S., Kuenne, C. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06406-8 · Cited by 91
The long and winding road to the mitochondrial pyruvate carrier
Schell, J. C., & Rutter, J. P. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-6 · Cited by 90
Drabovich, A. P., Pavlou, M. P., Dimitromanolakis, A., & Diamandis, E. P. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.015214 · Cited by 90
Chen, C., Liu, W.-R., Zhang, B., Zhang, L.-M., Li, C., Liu, C., Zhang, H., Huo, Y., Ma, Y.-C., Tian, P., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.009 · Cited by 90
Lew, C. R., & Tolan, D. R. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.405969 · Cited by 90
Rho GTPases and their roles in cancer metabolism
Wilson, K. F., Erickson, J. W., Antonyak, M. A., & Cerione, R. A. (2012) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2012.10.011 · Cited by 90
Cherry, S. R., & Lynch, K. W. (2020) · Genes & Development · doi:10.1101/gad.338962.120 · Cited by 90
Friedman, A. A., Tucker, G., Singh, R., Yan, D., Vinayagam, A., Hu, Y., Binari, R. C., Hong, P., Sun, X., Porto, M., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2002029 · Cited by 90
Chicken or the egg: Warburg effect and mitochondrial dysfunction
Senyilmaz, D., & Teleman, A. A. (2015) · F1000Prime Reports · doi:10.12703/p7-41 · Cited by 89
Ma, L., Wei, J., Wan, J., Wang, W., Wang, L., Yuan, Y., Yang, Z., Liu, X., & Ming, L. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1090-6 · Cited by 89
The Role of Mitochondrial Fat Oxidation in Cancer Cell Proliferation and Survival
Oliveira, M., & Liesa, M. (2020) · Cells · doi:10.3390/cells9122600 · Cited by 89
Mukherjee, J., Phillips, J. J., Zheng, S., Wiencke, J. K., Ronen, S. M., & Pieper, R. O. (2013) · PLoS ONE · doi:10.1371/journal.pone.0057610 · Cited by 89
The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of Radiobiology
Good, J., & Harrington, K. J. (2013) · Clinical Oncology · doi:10.1016/j.clon.2013.06.009 · Cited by 88
Emergence of MicroRNAs as Key Players in Cancer Cell Metabolism
Subramaniam, S., Jeet, V., Clements, J. A., Gunter, J. H., & Batra, J. (2019) · Clinical Chemistry · doi:10.1373/clinchem.2018.299651 · Cited by 88
Mohammad, G. H., Vassileva, V., Acedo, P., Damink, S. W. M. O., Malagó, M., Dhar, D. K., & Pereira, S. P. (2019) · Cancers · doi:10.3390/cancers11091372 · Cited by 88
Reactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer
Bhardwaj, V., & He, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103412 · Cited by 88
Zheng, D., Jiang, Y., Qu, C., Yuan, H., Hu, K., He, L., Chen, P., Li, J., Tu, M., Lin, L., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.08.002 · Cited by 88
Zhang, Y., Wu, M., Lu, W.-C., Li, Y., Chang, C. J., & Yang, J. (2024) · Cell Metabolism · doi:10.1016/j.cmet.2023.12.003 · Cited by 88
The altered metabolism of tumors: HIF-1 and its role in the Warburg effect
Stubbs, M., & Griffiths, J. R. (2009) · Advances in Enzyme Regulation · doi:10.1016/j.advenzreg.2009.10.027 · Cited by 88
The role of p53 in glucose metabolism
Cheung, E. C., & Vousden, K. H. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.12.006 · Cited by 88
Vázquez, A., Markert, E. K., & Oltvai, Z. N. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025881 · Cited by 88
Zhang, N., Liu, C., Jin, L., Zhang, R., Wang, T., Wang, Q., Chen, J., Yang, F., Siebert, H., & Zheng, X. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c04041 · Cited by 87
Wong, C. C., Au, S. L., Tse, A. P., Xu, M., Lai, R. K., Chiu, D. K., Wei, L. L., Fan, D. N.-Y., Tsang, F. H., Lo, R. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115036 · Cited by 87
Targeting MYC in cancer therapy: RNA processing offers new opportunities
Koh, C. M., Sabò, A., & Guccione, E. (2016) · BioEssays · doi:10.1002/bies.201500134 · Cited by 86
Hyperactivity of the transcription factor Nrf2 causes metabolic reprogramming in mouse esophagus
Fu, J., Xiong, Z., Huang, C. D., Li, J., Yang, W., Han, Y., Paiboonrungruan, C., Major, M. B., Chen, K., Kang, X., et al. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.005963 · Cited by 86
Yan, Q., Zeng, P., Zhou, X., Zhao, X., Chen, R., Qiao, J., Ling, F., Zhu, Z., Zhang, G., & Chen, C. (2021) · Oncogene · doi:10.1038/s41388-021-01666-z · Cited by 86
Marelli‐Berg, F. M., Fu, H., & Mauro, C. (2012) · Immunology · doi:10.1111/j.1365-2567.2012.03583.x · Cited by 86
Daniele, S., Giacomelli, C., Zappelli, E., Granchi, C., Trincavelli, M. L., Minutolo, F., & Martini, C. (2015) · Scientific Reports · doi:10.1038/srep15556 · Cited by 86
DeSouza, L. V., Romaschin, A. D., Colgan, T. J., & Siu, K. W. M. (2009) · Analytical Chemistry · doi:10.1021/ac802726a · Cited by 86
Marsh, J., Mukherjee, P., & Seyfried, T. N. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0213 · Cited by 86
Barone, V., Biczysko, M., Bloino, J., Cimino, P., Penocchio, E., & Puzzarini, C. (2015) · Journal of Chemical Theory and Computation · doi:10.1021/acs.jctc.5b00580 · Cited by 86
Reprogramming of central carbon metabolism in cancer stem cells
Wong, T. L., Che, N., & Ma, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.05.012 · Cited by 86
Nilsson, L. M., Plym Forshell, T. Z., Rimpi, S., Kreutzer, C., Pretsch, W., Bornkamm, G. W., & Nilsson, J. A. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002573 · Cited by 85
Age-dependent metabolic dysregulation in cancer and Alzheimer’s disease
Harris, R. A., Tindale, L. C., & Cumming, R. C. (2014) · Biogerontology · doi:10.1007/s10522-014-9534-z · Cited by 85
Yuen, C., Asuthkar, S., Guda, M. R., Tsung, A. J., & Velpula, K. K. (2016) · CNS Oncology · doi:10.2217/cns-2015-0006 · Cited by 85
Shimizu, K., & Matsuoka, Y. (2019) · Biotechnology Advances · doi:10.1016/j.biotechadv.2019.107441 · Cited by 85
Ji, Y., Yang, C., Tang, Z., Yang, Y., Tian, Y., Yao, H., Zhu, X. D., Zhang, Z., Ji, J., & Zheng, X. (2017) · Nature Communications · doi:10.1038/ncomms15308 · Cited by 84
High Expression of Glycolytic Genes in Cirrhosis Correlates With the Risk of Developing Liver Cancer
Lee, N. C. W., Carella, M. A., Papa, S., & Bubici, C. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00138 · Cited by 84
Coassolo, S., Davidson, G., Négroni, L., Gambi, G., Daujat, S., Romier, C., & Davidson, I. (2021) · Nature Communications · doi:10.1038/s41467-021-21960-4 · Cited by 84
Targeting glycogen metabolism in bladder cancer
Lew, C. R., Guin, S., & Theodorescu, D. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.111 · Cited by 84
Sakamoto, T., Niiya, D., & Seiki, M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.188714 · Cited by 84
Emerging Metabolic Targets in Cancer Therapy
Zhao, Y. (2010) · Frontiers in bioscience · doi:10.2741/3826 · Cited by 84
miRNAs link metabolic reprogramming to oncogenesis
Hatziapostolou, M., Polytarchou, C., & Iliopoulos, D. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.03.002 · Cited by 84
PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis
Nguyen, A., Loo, J. M., Mital, R., Weinberg, E. M., Man, F. Y., Zeng, Z., Paty, P. B., Saltz, L. B., Janjigian, Y. Y., de Stanchina, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83587 · Cited by 84
Developing proteomic biomarkers for bladder cancer: towards clinical application
Frantzi, M., Latosinska, A., Flühe, L., Hupe, M. C., Critselis, E., Kramer, M. W., Merseburger, A. S., Mischak, H., & Vlahou, A. (2015) · Nature Reviews Urology · doi:10.1038/nrurol.2015.100 · Cited by 83
The role of RNA alternative splicing in regulating cancer metabolism
Kozlovski, I., Siegfried, Z., Amar-Schwartz, A., & Karni, R. (2017) · Human Genetics · doi:10.1007/s00439-017-1803-x · Cited by 83
Tyrosine Kinase Signaling in Cancer Metabolism: PKM2 Paradox in the Warburg Effect
Wiese, E. K., & Hitosugi, T. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00079 · Cited by 83
The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis
Ruiz-Iglesias, A., & Mañes, S. (2021) · Cancers · doi:10.3390/cancers13071488 · Cited by 83
Chen, X., Li, Z., Yong, H., Wang, W., Wang, D., Chu, S., Li, M., Hou, P., Zheng, J., & Bai, J. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.03.023 · Cited by 84
Mitochondrial pyruvate import and its effects on homeostasis
Vanderperre, B., Bender, T., Kunji, E. R. S., & Martinou, J. (2014) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2014.10.008 · Cited by 83
Allosteric Mechanism of Pyruvate Kinase from Leishmania mexicana Uses a Rock and Lock Model
Morgan, H. P., McNae, I. W., Nowicki, M. W., Hannaert, V., Michels, P. A. M., Fothergill‐Gilmore, L. A., & Walkinshaw, M. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.079905 · Cited by 83
Dppa5 Improves Hematopoietic Stem Cell Activity by Reducing Endoplasmic Reticulum Stress
Miharada, K., Sigurðsson, V., & Karlsson, S. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.04.056 · Cited by 83
Novel drugs that target the metabolic reprogramming in renal cell cancer
van der Mijn, J. C., Panka, D. J., Geissler, A. K., Verheul, H. M. W., & Mier, J. W. (2016) · Cancer & Metabolism · doi:10.1186/s40170-016-0154-8 · Cited by 83
Phosphoglycerate dehydrogenase is dispensable for breast tumor maintenance and growth
Chen, J., Chung, F., Yang, G., Pu, M., Gao, H., Jiang, W., Yin, H., Capka, V., Kasibhatla, S., Laffitte, B., et al. (2013) · Oncotarget · doi:10.18632/oncotarget.1540 · Cited by 82
Li, Y., Wang, Y., Liu, Z., Guo, X., Miao, Z., & Ma, S. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00273 · Cited by 82
Comprehensive molecular characterization of urothelial bladder carcinoma
Weinstein, J. N., Akbani, R., Broom, B. M., Wang, W., Verhaak, R. G. W., Liu, W., Ju, Z., Motter, T., Peng, B., Ryan, M., et al. (2014) · Nature · doi:10.1038/nature12965 · Cited by 2,746
Modeling Core Metabolism in Cancer Cells: Surveying the Topology Underlying the Warburg Effect
Reséndis-Antonio, O., Checa, A., & Encarnación‐Guevara, S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012383 · Cited by 82
Elschenbroich, S., Ignatchenko, V., Clarke, B. A., Kalloger, S. E., Boutros, P. C., Gramolini, A. O., Shaw, P. H., Jurišica, I., & Kislinger, T. (2011) · Journal of Proteome Research · doi:10.1021/pr1011087 · Cited by 82
Zhao, Q., Caballero, O. L., Davis, I. D., Jonasch, E., Tamboli, P., Yung, W. K. A., Weinstein, J. N., Strausberg, R. L., & Yao, J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3708 · Cited by 82
PTBP1-associated microRNA-1 and -133b suppress the Warburg effect in colorectal tumors
Taniguchi, K., 酒井美来, Sugito, N., Kumazaki, M., Shinohara, H., Yamada, N. O., Nakayama, T., Ueda, H., Nakagawa, Y., Ito, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8005 · Cited by 82
Reznik, E., Christodoulou, D., Goldford, J. E., Briars, E. A., Sauer, U., Segrè, D., & Noor, Ε. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.08.066 · Cited by 82
Optimization of 13C isotopic tracers for metabolic flux analysis in mammalian cells
Walther, J. L., Metallo, C. M., Zhang, J., & Stephanopoulos, G. N. (2011) · Metabolic Engineering · doi:10.1016/j.ymben.2011.12.004 · Cited by 81
Mitochondrial remodeling in cancer metabolism and survival: Potential for new therapies
Barbosa, I. A., Machado, N. G., Skildum, A. J., Scott, P. M., & Oliveira, P. J. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.04.005 · Cited by 81
The Warburg effect: molecular aspects and therapeutic possibilities
Ngo, H. G., Tortorella, S. M., Ververis, K., & Karagiannis, T. C. (2014) · Molecular Biology Reports · doi:10.1007/s11033-014-3764-7 · Cited by 81
Follow the ATP: Tumor Energy Production: A Perspective
Oronsky, B. T., Oronsky, N. C., Fanger, G. R., Parker, C. T., Caroen, S. Z., Lybeck, M., & Scicinski, J. J. (2014) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520614666140804224637 · Cited by 82
Energy metabolism in cancer cells: How to explain the Warburg and Crabtree effects?
Antone, P. D. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.06.002 · Cited by 81
Nam, K., Oh, S., & Shin, I. (2016) · Biochemical Journal · doi:10.1042/bcj20160613 · Cited by 80
Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis
Guan, Y., Huang, Q., Ai, Y.-L., Chen, Q.-T., Zhao, W., Wang, X., Wu, Q., & Chen, H. (2020) · Oncogene · doi:10.1038/s41388-020-1158-y · Cited by 80
High glucose: an emerging association between diabetes mellitus and cancer progression
Supabphol, S., Seubwai, W., Wongkham, S., & Saengboonmee, C. (2021) · Journal of Molecular Medicine · doi:10.1007/s00109-021-02096-w · Cited by 80
Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
He, D., Feng, H., Sundberg, B., Yang, J., Powers, J., Christian, A. H., Wilkinson, J. E., Monnin, C., Avizonis, D. Z., Thomas, C. J., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.06.005 · Cited by 80
Liao, Q., Deng, J., Tong, J., Gan, Y., Hong, W., Dong, H., Cao, M., Chen, X., Chen, Y., Xie, B., et al. (2024) · Molecular Cell · doi:10.1016/j.molcel.2024.11.013 · Cited by 80
Parallels between embryo and cancer cell metabolism
Smith, D. G., & Sturmey, R. G. (2013) · Biochemical Society Transactions · doi:10.1042/bst20120352 · Cited by 80
Developmental insights into the pathology of and therapeutic strategies for DM1: Back to the basics
Chau, A. C., & Kalsotra, A. (2014) · Developmental Dynamics · doi:10.1002/dvdy.24240 · Cited by 81
Targeting PDK1 with dichloroacetophenone to inhibit acute myeloid leukemia (AML) cell growth
Qin, L., Tian, Y., Yu, Z., Shi, D., Wang, J., Zhang, C., Peng, R., Chen, X., Liu, C., Chen, Y., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6366 · Cited by 80
Extracellular Matrix Regulation of Metabolism and Implications for TumorigenesisPreprint
Grassian, A. R., Coloff, J. L., & Brugge, J. S. (2011) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2011.76.010967 · Cited by 80
Mitochondrial NDUFS3 regulates the ROS-mediated onset of metabolic switch in transformed cells
Suhane, S., Kanzaki, H., Arumugaswami, V., Murali, R., & Ramanujan, V. K. (2013) · Biology Open · doi:10.1242/bio.20133244 · Cited by 79
Snaebjornsson, M. T., & Schulze, A. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0065-6 · Cited by 79
Kwon, O., Kang, T.-W., Kim, J., Kim, S., Noh, S., Song, K., Yoo, H., Kim, W. H., Zhi, X., Pocalyko, D. J., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.063 · Cited by 79
Bistability in Glycolysis Pathway as a Physiological Switch in Energy Metabolism
Mulukutla, B. C., Yongky, A., Daoutidis, P., & Hu, W. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098756 · Cited by 79
Prakasam, G., Singh, R. K., Iqbal, M. A., Saini, S. K., Tiku, A. B., & Bamezai, R. N. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.791343 · Cited by 79
HIF1 mediates a switch in pyruvate kinase isoforms after myocardial infarction
Williams, A. L., Khadka, V. S., Tang, M., Avelar, A., Schunke, K. J., Menor, M., & Shohet, R. V. (2018) · Physiological Genomics · doi:10.1152/physiolgenomics.00130.2017 · Cited by 79
Metabolism during ECM Detachment: Achilles Heel of Cancer Cells?
Mason, J. A., Hagel, K. R., Hawk, M. A., & Schafer, Z. T. (2017) · Trends in Cancer · doi:10.1016/j.trecan.2017.04.009 · Cited by 78
MUC1-C Oncoprotein Regulates Glycolysis and Pyruvate Kinase m2 Activity in Cancer Cells
Kosugi, M., Ahmad, R., Alam, M., Uchida, Y., & Kufe, D. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028234 · Cited by 78
Ultrasensitive regulation of anapleurosis via allosteric activation of PEP carboxylase
Xu, Y., Amador‐Noguez, D., Reaves, M. L., Feng, X., & Rabinowitz, J. D. (2012) · Nature Chemical Biology · doi:10.1038/nchembio.941 · Cited by 78
O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth
Singh, J. P., Qian, K., Lee, J.-S., Zhou, J., Han, X., Zhang, B., Ong, Q., Ni, W., Jiang, M., Ruan, H., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0975-3 · Cited by 78
Keshari, K. R., Kurhanewicz, J. V., Jeffries, R. E., Wilson, D. M., Dewar, B. J., Criekinge, M. V., Zierhut, M. L., Vigneron, D. B., & Macdonald, J. M. (2010) · Magnetic Resonance in Medicine · doi:10.1002/mrm.22225 · Cited by 78
Tissue metabolic profiling of human gastric cancer assessed by 1H NMR
Wang, H., Zhang, H., Deng, P., Liu, C., Li, D., Jie, H., Zhang, H., Zhou, Z., & Zhao, Y. (2016) · BMC Cancer · doi:10.1186/s12885-016-2356-4 · Cited by 78
Yang, Y., Chien, M., Liu, H.-Y., Chang, Y., Chen, C.-K., Lee, W.-J., Kuo, T.-C., Hsiao, M., Hua, K., & Cheng, T. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.01.075 · Cited by 78
Metadata
- Authors
- Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C.
- Affiliations
- Harvard University (US)
- Boston Children's Hospital (US)
- Broad Institute (US)
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Cantley, Lewis C.
- ORCID
- Venue
- Nature
- Published
- 2008-03
- Volume
- 452
- Issue
- 7184
- Pages
- 230-233
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2015207840
- Cited by
- 2,820
- References
- 20
- Citations by year
- 2026: 68 · 2025: 101 · 2024: 133 · 2023: 142 · 2022: 151 · 2021: 174 · 2020: 169 · 2019: 170 · 2018: 190 · 2017: 158 · 2016: 180 · 2015: 204 · 2014: 211 · 2013: 187 · 2012: 186
- FWCI
- 44.09
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Cancer Institute (T32CA009172)
- National Institute of General Medical Sciences (R01GM056203)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cancer and biochemical research
- Keywords
- PKM2, alternative splicing, cancer metabolism, Warburg effect, aerobic glycolysis, carcinogenesis, phosphotyrosine binding, lactic acid production, oxygen consumption, glucose uptake, oxidative phosphorylation, tumor growth, glycolysis, tumor cell proliferation, tumor hypoxia
- MeSH terms
- Animals, Fructosediphosphates, Glycolysis, Humans, Lung Neoplasms, Male, Mice, Nude, Neoplasm Transplantation, Neoplasms, Oxidative Phosphorylation, Oxygen Consumption, Pyruvate Kinase, Gene Expression Regulation, Neoplastic, Alternative Splicing, Pyruvic Acid, Lactic Acid, Cell Line, Tumor, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review